64015-63-0Relevant academic research and scientific papers
Difunctionalization of Alkenes Using 1-Chloro-1,2-benziodoxol-3-(1H)-one
Egami, Hiromichi,Yoneda, Takahiro,Uku, Minako,Ide, Takafumi,Kawato, Yuji,Hamashima, Yoshitaka
, p. 4020 - 4030 (2016)
Difunctionalization of alkenes with 1-chloro-1,2-benziodoxol-3-(1H)-one (1) was investigated. Various additional nucleophiles were tested, and oxychlorination, dichlorination, azidochlorination, chlorothiocyanation, and iodoesterfication were demonstrated. The oxychlorination product was obtained efficiently when the reaction was operated in water. Dichlorination occurred in the presence of a Lewis basic promoter, such as 4-phenylpyridine N-oxide, as an additive. The reaction with in situ-generated azido anion afforded azidochlorinated compounds with a chlorine atom at the terminal position, while the reaction with trimethylsilyl isothiocyanate produced chlorothiocyanation adducts with a chlorine atom at the benzylic position. On the other hand, when 1 was treated with tetra-n-butylammonium iodide prior to the addition of alkenes, only iodoesterification occurred selectively. These mild reactions enable convenient site-selective difunctionalizations of substrates having two alkene moieties. NMR experiments suggested that the electrophilic reactive species in each reaction varied depending on the nature of the added nucleophile.
PROCESS FOR PRODUCING OPTICALLY ACTIVE HALOHYDRIN COMPOUND
-
, (2008/06/13)
A process of preparing an optically active halohydrin compound characterized by comprising asymmetric hydrogen transfer reduction of an α-haloketone compound in the presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound. The asymmetric hydrogen transfer reduction is preferably conducted in the presence of a base.
Novel benzylalcohol derivatives and processes for preparing the same
-
, (2008/06/13)
A compound of the formula: STR1 wherein R is lower alkyl, may be prepared, for example, by reducing a compound of the formula: STR2 wherein R is same as above. Other methods for preparing the compound [I] are also disclosed. The compound [I] and a pharmac
